<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MBBS 2nd Year Pharmacology - Smart Doctor Notes</title>
</head>
<body>
    <div class="container">
        <header>
            <h1>üß† MBBS 2nd Year Pharmacology</h1>
            <p><strong>Smart Doctor Notes - High Yield for Exams & Practice</strong></p>
        </header>

        <div class="chapter">
            <h2>üìö General Pharmacology</h2>
            <h3>Pharmacokinetics (ADME)</h3>
            <ul>
                <li><strong>Absorption:</strong> Passive diffusion (lipid soluble, non-ionized), Active transport, Facilitated diffusion</li>
                <li><strong>1st Pass Metabolism:</strong> Liver (morphine, propranolol ‚Üí reduced oral bioavailability)</li>
                <li><strong>Distribution:</strong> Plasma protein binding (‚Üì free drug), Volume of distribution (Vd)</li>
                <li><strong>Metabolism:</strong> Phase I (CYP450 oxidation), Phase II (conjugation ‚Üí water soluble)
                    <ul style="margin-top: 5px;">
                        <li><span class="drug">Inducers:</span> Phenytoin, Rifampicin, Carbamazepine, Phenobarbitone (<span class="mnemonic">PRCP</span>)</li>
                        <li><span class="adr">Inhibitors:</span> Cimetidine, Erythromycin, Ketoconazole, Grapefruit juice (<span class="mnemonic">CEKG</span>)</li>
                    </ul>
                </li>
                <li><strong>Excretion:</strong> Glomerular filtration (‚Üì in renal failure), Tubular secretion</li>
            </ul>

            <div class="highlight">
                <strong>Zero Order Kinetics:</strong> Alcohol, Phenytoin, Salicylates (>15g), <span class="drug">APSS</span>
            </div>

            <h3>Pharmacodynamics</h3>
            <ul>
                <li><strong>Receptors:</strong> GPCR (Œ≤-blockers), Ion channel (Lignocaine), Enzyme (Aspirin), Nuclear (Steroids)</li>
                <li><strong>Agonist:</strong> Full (Adrenaline), Partial (Buspirone)</li>
                <li><strong>Antagonist:</strong> Competitive (<span class="drug">Atropine</span>), Non-competitive (<span class="drug">Phenoxybenzamine</span>)</li>
            </ul>
        </div>

        <div class="chapter">
            <h2>‚ö° Autonomic Nervous System</h2>
            <h3>Cholinergic Drugs</h3>
            <ul>
                <li><span class="drug">Neostigmine:</span> Myasthenia gravis, Reversal of NMB</li>
                <li><span class="drug">Pilocarpine:</span> Glaucoma (miosis)</li>
                <li><span class="adr">Toxicity:</span> <span class="mnemonic">SLUD</span> (Salivation, Lacrimation, Urination, Diarrhea)</li>
                <li><span class="drug">Antidote:</span> Atropine</li>
            </ul>

            <h3>Anticholinergics</h3>
            <ul>
                <li><span class="drug">Atropine:</span> Organophosphate poisoning, Bradycardia</li>
                <li><span class="adr">ADRs:</span> Dry mouth, Blurred vision, Urinary retention, Tachycardia (<span class="mnemonic">DBUT</span>)</li>
            </ul>

            <h3>Sympathomimetics</h3>
            <table style="width:100%; border-collapse: collapse; margin: 15px 0;">
                <tr><th>Drug</th><th>Receptor</th><th>Main Use</th></tr>
                <tr><td><span class="drug">Adrenaline</span></td><td>Œ±1, Œ≤1, Œ≤2</td><td>Anaphylaxis, Cardiac arrest</td></tr>
                <tr><td><span class="drug">Noradrenaline</span></td><td>Œ±1&gt;Œ±2</td><td>Septic shock</td></tr>
                <tr><td><span class="drug">Dobutamine</span></td><td>Œ≤1&gt;Œ≤2</td><td>Cardiogenic shock</td></tr>
            </table>
        </div>

        <div class="chapter">
            <h2>‚ù§Ô∏è Cardiovascular System</h2>
            <h3>Antihypertensives (1st Line)</h3>
            <ul>
                <li><span class="drug">Thiazides:</span> HCTZ (Uncomplicated HTN)</li>
                <li><span class="drug">CCBs:</span> Amlodipine (Elderly)</li>
                <li><span class="drug">ACEIs:</span> Enalapril (Young, HF, DM)</li>
                <li><span class="adr">ACEI ADR:</span> Dry cough (switch to ARB: Losartan)</li>
            </ul>

            <h3>Heart Failure</h3>
            <ul>
                <li><span class="drug">Digoxin:</span> Toxicity = <span class="adr">Xanthopsia, Arrhythmias</span></li>
                <li><span class="drug">Drug Cocktail:</span> ACEI + Œ≤-blocker (Carvedilol) + Loop diuretic + Aldosterone antagonist (Spironolactone)</li>
            </ul>

            <h3>Anticoagulants</h3>
            <ul>
                <li><span class="drug">Heparin:</span> LMWH preferred (Enoxaparin)</li>
                <li><span class="drug">Warfarin:</span> Monitor PT/INR (2-3), Vitamin K antagonist</li>
                <li><span class="drug">DOACs:</span> Rivaroxaban (NO bleeding risk monitoring)</li>
            </ul>
        </div>

        <div class="chapter">
            <h2>üß† Central Nervous System</h2>
            <h3>Status Epilepticus</h3>
            <ol>
                <li><span class="drug">Lorazepam IV</span> (1st line)</li>
                <li><span class="drug">Phenytoin IV</span> loading</li>
                <li><span class="drug">Phenobarbitone</span> (3rd line)</li>
            </ol>

            <h3>Opioids</h3>
            <ul>
                <li><span class="drug">Morphine:</span> MI, Cancer pain</li>
                <li><span class="adr">Toxicity:</span> Pinpoint pupils, Respiratory depression</li>
                <li><span class="drug">Antidote:</span> <span class="drug">Naloxone</span></li>
            </ul>
        </div>

        <div class="chapter">
            <h2>ü•º Chemotherapy</h2>
            <h3>ATT (HRZE)</h3>
            <table style="width:100%; border-collapse: collapse; margin: 15px 0;">
                <tr><th>Drug</th><th>ADR</th></tr>
                <tr><td><span class="drug">Isoniazid</span></td><td>Hepatitis, Optic neuritis (Pyridoxine prophylaxis)</td></tr>
                <tr><td><span class="drug">Rifampicin</span></td><td>Orange urine, Enzyme inducer</td></tr>
                <tr><td><span class="drug">Pyrazinamide</span></td><td>Hyperuricemia</td></tr>
                <tr><td><span class="drug">Ethambutol</span></td><td>Optic neuritis</td></tr>
            </table>

            <h3>Antibiotics - Superbugs</h3>
            <ul>
                <li><span class="drug">MRSA:</span> Vancomycin, Linezolid</li>
                <li><span class="drug">Pseudomonas:</span> Piperacillin-tazobactam</li>
                <li><span class="drug">VRSA:</span> Linezolid</li>
            </ul>
        </div>

        <div class="chapter">
            <h2>üíä Clinical Pharmacology</h2>
            <div class="highlight">
                <strong>P-drug List (Personal Drugs):</strong> Choose 1-2 drugs per indication based on efficacy, safety, cost, familiarity
            </div>
            <ul>
                <li><strong>Prescription Writing:</strong> Generic name, Dose, Frequency, Duration, Instructions</li>
                <li><strong>Essential Medicine List (EML):</strong> WHO approved, cost-effective</li>
                <li><strong>FDC Critique:</strong> Avoid unless evidence-based (cobadex CZS = unnecessary)</li>
            </ul>
        </div>

        <footer>
            <p>üìñ <strong>Master these for:</strong> Theory (80%), Practical (20%), Clinical Practice (100%) | Review daily with <span class="mnemonic">mnemonics</span></p>
        </footer>
    </div>
</body>
</html>
